Needham & Company LLC Lowers Phreesia (NYSE:PHR) Price Target to $14.00

Phreesia (NYSE:PHR) had its price objective lowered by research analysts at Needham & Company LLC from $35.00 to $14.00 in a report issued on Tuesday. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 22.44% from the stock’s current price.

Other equities analysts have also issued research reports about the company. Mizuho decreased their price target on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Wall Street Zen cut shares of Phreesia from a “strong-buy” rating to a “buy” rating in a research report on Sunday, February 8th. Truist Financial set a $24.00 target price on shares of Phreesia in a research note on Thursday, January 8th. Citigroup reduced their price target on shares of Phreesia from $29.00 to $25.00 and set a “buy” rating on the stock in a research note on Friday, January 9th. Finally, DA Davidson decreased their price objective on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a report on Friday, January 23rd. Seventeen equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

Phreesia Price Performance

Phreesia stock opened at $11.43 on Tuesday. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average price of $12.51 and a 200 day moving average price of $17.68. Phreesia has a 12-month low of $10.75 and a 12-month high of $32.76. The stock has a market cap of $689.36 million, a P/E ratio of -114.33 and a beta of 0.67.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same period in the previous year, the firm posted ($0.11) EPS. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. Sell-side analysts anticipate that Phreesia will post -1.1 earnings per share for the current year.

Insider Buying and Selling at Phreesia

In other news, CFO Balaji Gandhi sold 3,829 shares of the company’s stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $11.26, for a total transaction of $43,114.54. Following the sale, the chief financial officer owned 146,740 shares of the company’s stock, valued at approximately $1,652,292.40. This represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Amy Beth Vanduyn sold 2,202 shares of Phreesia stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $36,024.72. Following the completion of the transaction, the senior vice president owned 157,349 shares of the company’s stock, valued at approximately $2,574,229.64. This trade represents a 1.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 70,358 shares of company stock valued at $1,123,569. Insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PHR. Raymond James Financial Inc. grew its position in shares of Phreesia by 2.7% during the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after acquiring an additional 375 shares during the last quarter. Diversified Trust Co boosted its stake in Phreesia by 1.7% during the 3rd quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock worth $1,078,000 after purchasing an additional 780 shares during the period. Alliancebernstein L.P. grew its position in Phreesia by 1.3% during the 3rd quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock worth $1,475,000 after purchasing an additional 812 shares during the last quarter. Van ECK Associates Corp increased its position in Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after acquiring an additional 1,102 shares during the period. Finally, Arizona State Retirement System lifted its position in Phreesia by 8.1% during the 3rd quarter. Arizona State Retirement System now owns 17,608 shares of the company’s stock worth $414,000 after acquiring an additional 1,313 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Key Stories Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.